-
1.发明申请Collyrium For The Treatment Of Conical Cornea With Cross-Linking Trans-Epithelial Technique 审中-公开Collyrium治疗锥形角膜与交叉连接上皮上皮细胞技术公开(公告)号：US20100286156A1
公开(公告)日：2010-11-11
申请号：US12436355
申请日：2009-05-06
申请人： Roberto PINELLI
发明人： Roberto PINELLI
IPC分类号： A61K31/525
CPC分类号： A61K31/525 , A61K9/0048
摘要： A collyrium for the treatment of patients suffering from conical cornea contains a riboflavin photosensitizing substance and a surface-active agent to assist penetration of the collyrium into the corneal epithelium. The collyrium does not require removal of the corneal epithelium, with the absence of pain for the patient, who does not need post treatment therapy, and who no longer complains of edema due to the prior art removal of the epithelium, thereby preserving the original corneal transparency.
摘要翻译： 用于治疗患有锥形角膜的患者的阴囊包含核黄素光敏物质和表面活性剂，以帮助胶质细胞渗入角膜上皮细胞。 阴茎不需要去除角膜上皮，患者没有疼痛，不需要治疗后治疗，并且由于现有技术去除上皮而不再抱怨水肿，从而保留原始角膜 透明度。
-
公开(公告)号：US20240184144A1
公开(公告)日：2024-06-06
申请号：US18287457
申请日：2022-03-30
申请人： Roberto PINELLI
发明人： Roberto PINELLI
摘要： The present invention relates to an optical filter for modulating electromagnetic waves which make up a light radiation. configured in such a way as to allow the exclusive transmission of electromagnetic waves which have a wavelength comprised between 520 nm and 590 nm to implement a photobiomodulation treatment. The optical filter comprises a first support layer (1), made of polymeric material and comprising a vegetable pigment derived from lutein, and a second polarizing layer (2).
-
公开(公告)号：US20190010453A1
公开(公告)日：2019-01-10
申请号：US16065795
申请日：2016-12-20
申请人： Roberto PINELLI
发明人： Roberto PINELLI
摘要： The present invention regards stem cells isolated from the ora terminalis and ora serrata regions of the retina, a method for isolating said stem cells, and their use in the treatment of diseases and other pathological conditions that affect the eyes.
-
公开(公告)号：US20190008832A1
公开(公告)日：2019-01-10
申请号：US16067247
申请日：2016-12-22
申请人： Roberto PINELLI
发明人： Roberto PINELLI
IPC分类号： A61K31/4178 , A61P27/10 , A61K9/00
摘要： The present invention relates to a composition comprising (a) pilocarpine or pharmaceutically acceptable salts thereof, (b) at least one alpha-stimulant agonist or pharmaceutically acceptable salts thereof and/or (c) at least one nonsteroidal anti-inflammatory agent (NSAID) or pharmaceutically acceptable salts thereof wherein (a) is present in a percentage by weight lower than 0.40%, (b) and/or (c) is present in a percentage by weight lower than 0.090% based on the total volume of the composition.
-
-
-
搜索结果
4 条记录 (耗时 0.015 秒)
